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Abstract
Infective endocarditis (IE) is an infectious disease that is mainly caused by Staphylococcus aureus and Streptococcus sp. It
usually leads to valvular destruction and vegetation formation. Its pathophysiology is badly understood and likely involves
immune and coagulation systems with close interactions with the microorganism. Our objective was to evaluate host
response by comparing transcriptional profiles of cardiac valves from IE patients with controls. Hierarchical clustering
revealed a signature of IE consisting of 146 genes. Among the 89 up-regulated genes, we identified two genes strongly
associated with IE: metalloproteinase 12 (MMP-12) and aquaporin-9, a member of the aquaglyceroporin membrane channel
family. The up-regulation of MMP-12 gene is strengthened by the down-modulation of the gene encoding its inhibitor
TIMP3. In addition, MMP-12 was expressed in macrophages infiltrating EI valves. We also found that aquaporin-9 was
expressed in endothelial cells lining neo-vessel lumen, suggesting that aquaporin-9 might be associated with
neovascularization of infected valves leading to tissue oedema secondary to the inflammatory process. The Gene Ontology
annotation and the resulting functional classification showed that most up-regulated genes account for recruitment of
inflammatory cells in vegetations, angiogenesis and remodelling of endocardium tissue. A network analysis confirmed the
involvement of molecules related to the remodelling of endocardium tissue and angiogenesis in IE. It also evidenced the
role of caspases, especially that of caspase-9 and intrinsic apoptotic pathway in IE. Based on this study we propose a
scenario for the natural history of IE in humans. Some parameters identified in this work could become tools for measuring
the disease activity and should be tested as biomarkers for diagnosis or prognosis assessment in future studies.
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Introduction
Infective endocarditis (IE) is a rather common disease causing
high morbidity and mortality despite the availability of
antimicrobial agents and cardiac surgery. Usually, IE is
diagnosed by the culture of microorganisms (mainly Staphylococcus
aureus and Streptococci sp.) from blood and echocardiographical or
histological detection of vegetations. This lesion results from the
formation of a coagulum consisting of plasma and platelet
proteins [1]. Pathogens associated with IE bind the coagulum
and colonize the lesion [1–3]. Most of the studies on IE
pathophysiology have been obtained in experimental animals
and show that the recruitment of circulating cells including
neutrophils and monocytes is secondary to tissue reorganization
and bacterial colonization [4,5]. Cell recruitment leads to the
release of cytokines and procoagulant factors and, consequently,
to the enlargement of the vegetation. In addition, whereas
normal heart valves are not vascularized, because of the
expression of the anti-angiogenic factor chondromodulin-1, IE
is associated with neo-vascularization [6]. Infecting pathogens
survive inside vegetations by avoiding host defences, and the final
step of IE consists of the dissemination of septic embols to distant
organs and the destruction of valve tissues [7]. To investigate this
complex host response, we studied the whole transcriptional
activity of patient valves in the attempt to identify the major
molecular pathways involved in IE pathophysiology. We
consequently propose a scenario for the natural history of IE in
humans and also suggest that some parameters identified in this
work could become tools for measuring the disease activity and
should be tested as biomarkers for diagnosis or prognosis
assessment in future studies.
Results and Discussion
As IE is histologically characterized by infiltrates of inflamma-
tory cells and neo-angiogenesis, we studied the expression of CD15
and CD68 as markers of neutrophils and macrophages, respec-
tively, and Factor VIII as an angiogenesis marker. In valves from
controls, no neutrophil, macrophage and factor VIII-expressing
cells were detected (Fig. 1A–B). In contrast, the valves from
patients with IE due to Streptococcus (Fig. 1C–D) or S. aureus
(Fig. 1E–F) expressed CD15, CD68 and Factor VIII. CD15
represented 1–3%, and CD 68 and Factor VIII about 5% of the
total area of the valves (Fig. 1G).
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tional profiles of cardiac valves from 5 patients with IE, caused by
either S. aureus or Streptococcus sp. and 7 controls with uninfected
valvular heart diseases. In addition, we included one cardiac valve
from a patient with suspected IE, i.e. exhibiting histological
features of IE (low expression of CD15 and CD68, and high
expression of Factor VIII, Fig. 1G) but negative blood culture.
Among the 33,492 sequences (41,000 reporters) of the microarray,
only annotated genes (18,083 genes) and those with
P-valuepres ,0.01 and a coefficient variation .0.3 (11,404 genes)
were used for global clustering analysis and differential analysis
between IE and controls; genes with P-valuediff ,0.01 and an
absolute fold change (FC) .3.0 were considered as differentially
expressed. The IE signature consisted of 146 genes, 89 being up-
regulated with FC ranging from 3.1 to 58.9 (Table S1), and 57
genes down-modulated with FC ranging from 23.1 to 214.9
(Table S2). The transcriptional profiles of patients were organized
in a common cluster placed on a branch distinct from controls
(Fig. 2). Interestingly, the transcriptional profile of the cardiac
valve from the patient with suspected IE (patient IE6) clustered
with those of IE patients (Fig. 2). This suggests that the gene
expression profile of heart valves enables to discriminate patients
with IE from controls. It is noteworthy that the transcriptional
programme of IE valves reflected the level of leucocyte infiltration.
We identified the neutrophil signature (27 genes) but not the
lymphocyte signature (Fig. S1) previously reported in isolated cells
[8].
We then analyzed IE-associated genes by using the Gene
Ontology (GO) annotation and the resulting functional classifica-
tion. We found enriched GO terms related to immune response,
inflammatory response, chemotaxis, proteolysis, cellular defence
response, defence response to bacteria, cell-cell signalling, calcium
homeostasis and positive regulation of cell proliferation (Fig. 3).
They may be classified in four functional groups: immune
response, structural organization or remodelling, proliferation/
Figure 1. Histological analysis of cardiac valves. (A–F) Samples of
cardiac valves from controls (A, B) and patients with IE due to
Streptococcus (C, D) or S. aureus (E, F) were stained with haematoxylin-
eosin-saffron. Representative micrographs are shown. Note the absence
of vegetations and inflammatory infiltrates in controls. In IE patients,
inflammatory infiltrates are mainly developed on the surface of the cusp
of valves, within the vegetations. Left and right, 625 and 6100
magnifications, respectively. (G) Valve sections were analyzed by
immunohistochemistry and quantitative image analysis to determine
the expression of CD15, CD68 and Factor VIII. The normalized results are
expressed as the percentage of valve sample area covered by
neutrophils, macrophages and endothelial cells, respectively. They
represent the mean values, and the minimum and the maximum are
shown in parentheses.
doi:10.1371/journal.pone.0008939.g001
Figure 2. Hierarchical clustering analysis of transcriptional
profiles of patients. Only 18,083 genes, which were expressed with a
P-value ,0.01 and a CV .0.3 in at least one condition, were included in
the analysis. Data were converted to z-score prior gene and sample
classifications by unsupervised hierarchic clustering using the average
linkage method and Cosine correlation coefficient as the distance
metric. The hierarchical clustering of a selection of 146 genes
differentially expressed by IE and controls is showed, with a colour
gradient (Z-score) from green (down-regulation) to red (up-regulation).
doi:10.1371/journal.pone.0008939.g002
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tent with mechanisms described in animal models of IE, i.e.,
recruitment of cells in vegetations, remodelling of endocardium
tissue and neo-angiogenesis [4]. The down-modulated genes in IE
valves mainly belong to structural organization or remodeling
(n=9), proliferation/death (n=7), metabolism (n=7) and miscel-
laneous (n=31) functional groups. No gene involved in inflam-
matory, immune and defence responses to bacteria was down-
modulated (Table S2).
An important step in vegetation genesis during experimental IE
is leucocyte attraction and angiogenesis [4]. In this study, we
showed a large number of up-regulated genes involved in
chemotaxis with FC ranging from 3.9 to 58.9 (Table S1). These
genes encode both CXC chemokines (CXCL1, CXCL4, CXCL5,
CXCL6, CXCL7, CXCL13) involved in neutrophil recruitment,
and CC chemokines (CCL7, CCL8, CCL13, CCL18, CCL20,
CCL23) involved in the trafficking of myeloid and T cells [9]. The
up-regulation of CCL13, CXCL1, CXCL5 and CXCL6 genes
was confirmed by qRT-PCR in these patients and another set of 9
patients (Fig. S2). CXCL1, CXCL4 and CXCL5 have pleiotropic
functions including neutrophil activation and adhesion of
monocytes to endothelial cells [10]; CXCL6, largely produced
by mesenchymal cells in response to inflammatory mediators, is
cleaved by group A Streptococcus protease, which abrogates its
activity [11]; CCL13 is involved in the migration of monocytes, T
cells and eosinophils [12]; CCL20 mediates the recruitment of T
cells and dendritic cells, and is expressed by Th17 cells [13];
CCL18 is associated with M2 polarization of macrophages [14].
Altogether, this large panel of up-regulated genes encoding
chemokines suggests that the attraction of leucocytes to the
vegetation, including dendritic cells as recently reported [15], is
one crucial step of vegetation development. Chemokines, such as
CXCL1, CXCL6 and CXCL16, are involved in angiogenesis [9],
and the genes encoding these chemokines were up-regulated in
patients. CXCL16 is also expressed in valves from patients with
rheumatic or atherosclerotic diseases, and may be necessary for
the recruitment of CD8
+ T cells during inflammatory valvular
heart disease [16].
Tissue remodeling is a prerequisite for vegetation development
by promoting leucocyte transmigration. In vitro experiments show
that recruited monocytes in valvular lesions contribute to the
formation of vegetations by producing tissue factor and enhancing
fibrin deposition [17]. Experimental models of IE using Staphylo-
coccus epidermidis-o rS. aureus-infected rabbits reveal the production
of tissue factor by monocytes infiltrating vegetations [4,18].
Moreover, there is a correlation between the numbers of
infiltrating monocytes and bacteria inside the vegetation [18].
Among the 16 genes involved in tissue remodelling that were
Figure 3. GO annotation of modulated genes. Differentially expressed genes in IE were subjected to GO annotation to identify the
corresponding biological process. The major biological processes are shown, including the number of genes for each of the processes, and the
percentage of differentially expressed annotated genes. GO redundancy is due to the involvement of individual genes in multiple biological
processes.
doi:10.1371/journal.pone.0008939.g003
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regulated. They included a disintegrin and metalloproteinase
(MMP12), also known as ADAM12 (Table S1). The expression of
MMP12 was assessed by RT-PCR (Fig. S3) and immunohisto-
chemistry (Fig. S4). MMP-12 transcripts were higher in IE valves
than in controls, and the MMP-12 molecule was expressed in
macrophages infiltrating IE valves, reflecting the inflammatory
response of IE valves. MMPs, a family of endopeptidases that are
secreted as latent zymogens, are involved in the pathogenesis of
vascular disorders [19] and the remodelling of valvular tissues in
endocarditis and degenerative valvular diseases [20]. The activities
of MMPs are controlled at three distinct levels: gene expression,
activation of the proenzyme forms of the MMPs, and inhibition of
activity by complexing with their specific tissue inhibitors (TIMPs)
[21]. Interestingly, TIMP-3 was down-modulated in IE patients
(Table S2 and Fig. S3). Combined with increased expression of
MMP-12, it may exacerbate valvular inflammation. As plasmin
and thrombin activate MMPs, it is likely that the coagulation-
fibrinolysis system can stimulate the MMPs leading to valvular
destruction and embolization.
An anti-infectious response was also identified in IE valves
(Table S1). First, it included the up-regulated expression of genes
encoding chemokines, including CXCL1, CXCL13, CCL13,
CCL18 and CCL20, with antimicrobial activity against bacteria
such as S. aureus or S. pyogenes [22]. Second, it included members of
C-type lectin domain superfamily, such as CLEC4D (with the
highest FC), macrophage receptor with collagenous structure
(MARCO, see Fig. S3) and leukocyte immunoglobulin-like
receptors (LILR) B2 and B5. C-type lectins, characterized by the
presence of one or more C-type domains, are able to bind
microorganisms, activate complement and exert direct antimicro-
bial activity. These sensors of pathogens and cellular damage are
mainly expressed by myeloid cells found in IE valves [23]. Third,
the over-expression of the gene encoding granzyme B (see Fig. S3),
a protease of cytotoxic CD8
+ T cells, may be related to the
presence of CD8
+ T cells close to endothelial cells in inflammatory
valve diseases [16] and in IE (our results). Fourth, three
inflammatory cytokines, namely interleukin (IL)-1a (see Fig. S3),
IL-24 and TNFSF14, were over-expressed in IE. Fifth, two
members of the aquaglyceroporin membrane channel family
classification were modulated in IE. The expression of aquaporin
(AQP)-9 gene was increased by 18 fold in IE valves (see Fig. S3)
and that of AQP-7 gene was down-modulated (Table S2). AQPs
are cell membrane-embedded proteins that facilitate movement of
water by increasing membrane water permeability and water flux
in response to osmotic gradients [24]. They differ in their
transcriptional regulation [25]. The AQP family can be divided
into two groups on the basis of their permeability characteristics.
Most members of the first group (AQP) are only permeated by
water. Members of the second group (aquaglyceroporins), which
includes AQP7 and AQP9, are permeated by water to varying
degrees and other small solutes such as glycerol [24]. AQPs are
involved in many pathological processes including myocardial
oedema related to the ischemia-reperfusion phenomena [26].
AQP-7 is preferentially associated with adipose cardiac tissue
[27,28]. At our knowledge, the potential implication of AQPs in
heart valve diseases has never been reported. However, recent
works identified the ubiquitous expression of AQP water channels
in the endothelial cells of most organs and their implications in the
water movement across the capillary bed into the interstitial space
[29]. As we found that AQP9 was expressed in endothelial cells
lining the lumen of neo-vessels as demonstrated by immunohis-
tochemistry (Fig. S4), we can speculate that the high increase in
AQP9 expression observed during IE might be associated with the
neo-vascularization of the infected valve leading to tissue oedema
secondary to the inflammatory process.
Functional networks were identified using GO classification and
web-based entry tool. We selected only interactions in which at
least 2 references can be extracted from the literature. The first
network associated with cell adhesion consisted of 13 genes mostly
down-regulated (11 of 13 genes) (Fig. 4A). The second network was
associated with extracellular matrix polymerization (Fig. 4B). The
third network consisted of coagulation-related genes and related
MMP genes (Fig. 4C). The coagulation network included 10 up-
regulated genes such as PLAU, CTSG (cathepsin G) and F12
(coagulation factor 12), and 7 down-modulated genes such as
KLKB1 (kallikrein B1), FVII and X (coagulation factor VII and
X). Moreover, 5 genes encoding MMPs and that encoding furin,
an endoprotease, were up-regulated in the network. This network
analysis is consistent with the expression of coagulation factors and
isolated MMPs in pathological valves [20,30]. Moreover, our
analysis revealed an apoptosis network, including 10 caspases and
5 related molecules (Fig. 4D). The caspase-8 gene was down-
modulated and the caspase-9 gene was over-expressed in IE
patients. As they are involved in the extrinsic and intrinsic
apoptotic ways [31], respectively, it is likely that only caspase-9 is
involved in IE. This is in accordance with recent data that showed
activated caspases in leucocytes from patients with valvular
diseases [32]. In an animal model, scintigraphic measurement of
apoptosis confirms the presence of apoptotic cells in the vicinity of
vegetations [33].
The whole genome analysis of cardiac valve transcriptome led
us to propose a scenario for IE pathophysiology that relies gene
expression and tissue lesions. In patients with valve defect, the
blood flow is turbulent rather than linear [34] and this leads to the
apoptosis of cells projected on cardiac valve (apoptosis network)
(Fig. 5A). This is the initial event leading to tissue remodelling
(extracellular matrix polymerization and coagulation networks)
generating primary aseptic clot (Fig. 5B). Modified tissues enable
microbial colonization and the recruitment of neutrophils and
monocytes (chemotaxis) leading to the constitution of the
vegetation (Fig. 5C). Then, tissue remodelling and neo-angiogen-
esis components (proteolysis and chemotaxis) destroy progressively
the valve generating a risk of cardiac embolization and cardiac
insufficiency (Fig. 5D). Based on this scenario, we suspected that
the detection of apoptotic cells in the blood of patients with valve
lesion may be associated with an increased risk of IE. This may be
of great clinical impact to identify patients at risk. The prognosis
value of circulating levels of MMP-12 and AQP-9 should be
investigated in patients.
Materials and Methods
Patients
Ethics statement. Informed and written consent was obtained
from each subject and the study was approved by the Ethics
Committee of the Universite ´d el aM e ´diterrane ´e.
The study consisted of a retrospective series of heart valve
samples from 15 Caucasian patients hospitalized because of
clinical suspicion of IE [35]. The15 tissue specimens analyzed in
the present study were randomly selected from all the patients who
underwent surgery for a first episode of left-sided native valve
endocarditis between January 2006 and January 2008. The
diagnosis of IE was based on the modified Duke’s criteria [36]
that include clinical data, blood cultures, immunohistochemical
analyses of cardiac valves and molecular detection of organisms in
blood and cardiac valves. Among IE patients, 5 patients (3 males
and 2 females, median age: 59.6 years, range: 45–77 years)
Infective Endocarditis
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median age: 52.5 years, range: 25–75 years) from IE due to
Streptococcus sp. and 1 patient had an uncertain IE (one male, age:
59 years). As controls, we used cardiac valve samples from 12
patients (10 males and 2 females, median age: 61.8 years, range:
31–83 years) with pre-existing cardiac diseases. Thirteen samples
Figure 4. Network analysis in IE. Differentially expressed genes in IE were subjected to GO annotation according cell adhesion (A), extracellular
matrix polymerization (B), proteolysis (C) and caspase (D) networks. Only entities with binding partners are represented. Note that the proteolysis
network included coagulation and MMP pathways that were connected whereas caspase pathway was isolated.
doi:10.1371/journal.pone.0008939.g004
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microarrays and all the samples were analyzed by real-time
quantitative RT-PCR.
Histological Analysis
Valve tissue samples were fixed in formalin, embedded in
paraffin, cut to 3 mm in thickness and stained with haematoxylin-
eosin-saffron using routine methods. The immunohistological
procedure, in which a peroxidase-based method was used, is
described elsewhere [37]. Paraffin sections were stained with the
ready-to-use CD15 (BD Biosciences, Le Pont de Claix, France),
CD68 and Factor VIII (Dako, Trappes, France). The CD15-,
CD68- and Factor VIII-positive surfaces were analyzed in tissue
samples by quantitative image analysis, as described elsewhere
[38]. In brief, immunohistological images were digitized and the
image analyzer Samba 2005 (Samba Technologies, Alcatel TITN,
Grenoble, France), which provides a visual control of analysis,
allows the calculation of the percentage of the total surface area
covered by the specific marker. For each set of observations, the
surfaces of 10 randomly chosen areas were studied at a
magnification of 6100, and the surface areas covered by
neutrophils, macrophages and endothelial cells, respectively, were
measured. The results are expressed in mean, with the minimum
and the maximal values. MMP-12 and AQP9 were detected
according a similar procedure with specific antibodies purchased
from R&D Systems (Lille, France) and Chemicon (Millipore,
Mosheim, France), respectively.
Total RNA Extraction
Cardiac valve samples were collected in RNase-free tubes
containing RNAlater, a stabilization reagent. Tissue (10 mg) is then
lysed with the TissueLyzer (Qiagen, Hilden, Germany) and total
RNA was extracted using the RNeasy Mini kit (Qiagen) as
previously described [32]. DNase treatment was performed with
the DNase RNase-free set (Qiagen). RNA quality and quantity
were assessed with the 2100 Bioanalyzer (Agilent Technologies,
Santa Clara, California, USA) and the NanoDrop Spectropho-
tometer (NanoDrop Technologies, Wilmington, Delaware, USA).
Microarray Experiments
Human 4644k 60-mer oligonucleotide microarray slides
(Agilent Technologies) and one-color experimental design were
used as recently described [39]. All experiments were performed in
an ozone-free area to ensure the stability of the cyanine 3 (Cy3).
Sample labelling and hybridization were performed according to
protocols specified by the manufacturer (One-Color Microarray-
Figure 5. Putative scenario for IE. The natural history of IE may be decomposed in successive steps including cell apoptosis that may be
promoted by blood turbulence in the vicinity of valve lesion (A), procoagulant activity that results in fibrin and platelet deposition (B), bacterial
colonization and chemoattraction of neutrophils increasing vegetation size (C), tissue remodelling and neoangiogenesis leading to the functional
destruction of the valve (D). At this stage, the situation is irreversible and cardiac surgery is necessary.
doi:10.1371/journal.pone.0008939.g005
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and Cy3-labeled CTP fluorescent dyes were used to generate
fluorescent cRNA with Low RNA Input Fluorescent Amplification
Kit (Agilent Technologies). The dye-incorporation ratio and the
cRNA quantity were determined using the Nanodrop spectropho-
tometer. For hybridization, 1.65 mg of Cy3-labeled cRNA was
added on microarray slide for 17 hours using the Hybridization
Oven kit procedure provided by Agilent Technologies. Slides were
then washed, dried, and scanned at 5 mm resolution with a
G2505B DNA microarray scanner (Agilent Technologies).
Analysis of Microarray Experiments
Image analysis and intra-array signal correction (one-color
analysis default setting) were performed using Feature Extractor
Software A.9.1.3 (Agilent Technologies). The use of Rosetta error
model is suitable to improve the analysis of experiments with a
small number of samples. Data processing, analysis and visualizing
were performed using Resolver software 7.1 (Rosetta Inphar-
matics, Seattle, WA) and its intensity error model pipeline
optimized for the gene expression analysis of microarrays. The
intensity error model and its applications have been detailed by
Weng et al. [40]. Briefly, reporter mapping to genes was computed
by performing a squeeze operation that created intensity profiles
by combining replicates while applying error weighting. To know
whether a gene was present in transcripts a hypothesis test was
used. Negative control sequences were used to estimate the
parameters of the null distribution and P-value (P-valuepress) was
calculated for each particular sequence. When P-valuepres ,0.01,
we rejected the null hypothesis and accepted the alternative
hypothesis that the sequence transcript was present in the
microarray. Before error-weighted combining of samples in IE
vs. controls, an inter-array global normalization was performed
using the average of intensities from all positive or present genes.
Discrimination between sample groups (IE vs. controls) was
studied using an error-model-based hypothesis test. The null
hypothesis was that the gene is not differentially expressed. A
differential expression of P-value (P-valuepres) involving parameters
of the error model was computed for each particular sequence to
compare gene expression between two category groups. In
addition, FC (ratios in log 10 scale) were also computed using
an error-weighted ratio combination method. For P-valuediff ,
0.01 and absolute FC .3.0, the gene was considered as
differentially expressed.
The GO viewer tool was used to calculate P-value for each GO
term. An exact hypergeometric distribution allowed the comparison
of the frequencies of individual GO terms within the IE signature
with the frequencies of those terms on the entire microarray
(P,0.05 was considered to be significant). In order to increase
meaningfulness and clarity, the output GO term list was filtered to
only keep GO terms constituted of at least 5 genes belonging to the
IE signature. Significant GO terms are separated in 3 categories:
cell component, molecular function or biological process. For each
GO term category, a 2D-cluster was performed considering
significant GO terms vs. sample groups (controls and IE). We
classified the GO terms by unsupervised hierarchic clustering, using
theaverage linkagemethod andCosinecorrelation coefficientasthe
distance metric whereas the sample group order was supervised. All
data were entered in the ArrayExpress database following the
MIAME procedure [41] and can be retrieved using the accession
number E-MEXP-1334. Functional classification was determined
using numerous databases: DAVID Bioinformatics Resources
2008 (http://david.abcc.ncifcrf.gov/), Online Medelian Inheri-
tance in Man (http://www.ncbi.nlm.nih.gov/sites/entrez?db=
OMIM&TabCmd=Limits), SOURCE (http://smd.stanford.edu/
cgi-bin/source/sourceSearch), gand Babelomics Fatigo+ (http://
babelomics2.bioinfo.cipf.es/fatigoplus/cgi-bin/fatigoplus.cgi).
The connection between genes was studied using networks
generated by PathwayStudio
TM (Ariadne Genomics) as recently
described [39]. Briefly, networks were built by connecting entities
with binding relations stored in the ResNet 6 mammal database.
Ratio data from microarray experiments were used to colourized
entities. Red colour corresponded to up-regulated genes in valves
from IE patients compared to valves from controls and blue colour
to down-regulated genes.
Reverse Transcription and Quantitative Real-Time PCR
(qRT-PCR)
The cDNA synthesis was carried out with 10 ng of total RNA,
oligo(dT) primer and M-MLV reverse transcriptase (Invitrogen,
Cergy Pontoise, France) according to the manufacturer’s protocol.
PCR was performed using the Light Cycler from Roche
Diagnostics (Meylan, France). Briefly, amplification was conducted
in a 20 ml volume using Syber Green PCR Maxter mixture (Roche
Diagnostics), 2 ml of template cDNA, 1 ml (10 pmol) each of
forward and reverse gene-specific primers, 2 ml of 3 mM MgCl2
and 12 mlH 2O. The primers (Table S3) were designed using the
primer3 tool (http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_
www.cgi). RT was omitted in negative controls. The FC in target
gene cDNA relative to the b-actin endogenous control was
determined as follows: FC=2
2DDCt, where DDCt=(CtTarget -
CtActin)IE - (CtTarget - CtActin)controls. Ct values were defined as
the number of cycles for which the fluorescence signals were
detected [42]. Results from the 14 patients with IE and the 12
controls are represented as FC median with 25 and 75 percentile
distribution, and minimum and differences were considered
statistically significant at a value of P,0.05.
Supporting Information
Figure S1 Cellular signatures of cardiac valves. The list of genes
corresponding to neutrophil (A) and lymphocyte (B) signatures is
shown. Red colour corresponds to up-regulated genes, blue colour
to down-regulated genes and grey colour to unexpressed genes in
IE patients compared with controls.
Found at: doi:10.1371/journal.pone.0008939.s001 (0.16 MB TIF)
Figure S2 Modulation of 4 genes encoding chemokines using
qRT-PCR. The expression levels of 4 genes found up-regulated by
microarray were determined by qRT-PCR and normalized with
the b-actin gene. Results of cardiac valves from 12 controls (C) and
14 IE patients are represented as median with 25 and 75 percentile
distribution, and minimum and maximum values. *P,0.05.
Found at: doi:10.1371/journal.pone.0008939.s002 (0.06 MB TIF)
Figure S3 Modulation of different genes using qRT-PCR. The
expression levels of 6 genes found up-regulated and one down-
regulated by microarray were determined by qRT-PCR and
normalized with the b-actin gene. Results of cardiac valves from
12 controls (C) and 14 IE patients are represented as median with
25 and 75 percentile distribution, and minimum and maximum
values. *P,0.05.
Found at: doi:10.1371/journal.pone.0008939.s003 (0.06 MB TIF)
Figure S4 Immunodetection of MMP-12 and AQP9 in IE
valves. Valve tissue samples from 3 IE patients were freezed and
cut to 3 mm in thickness. MMP-12 and AQP9 were revealed
using specific antibodies (1/100 and 1/200 dilutions, respec-
tively) and secondary antibodies coupled with peroxidase.
Magnification: 6400.
Found at: doi:10.1371/journal.pone.0008939.s004 (4.64 MB TIF)
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Found at: doi:10.1371/journal.pone.0008939.s005 (0.18 MB
DOC)
Table S2 Genes down-modulated in IE
Found at: doi:10.1371/journal.pone.0008939.s006 (0.15 MB
DOC)
Table S3 Primers used for qRT-PCR
Found at: doi:10.1371/journal.pone.0008939.s007 (0.03 MB
DOC)
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